Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
BelgiumStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
FranceStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
AustriaStudy on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus
The NetherlandsStudy on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma
PolandStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
AustriaStudy on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial
BelgiumStudy on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients
SpainStudy on the Safety and Effectiveness of Fostemsavir for Patients with Multi-drug Resistant HIV-1 Who Have Had Extensive Previous Treatments
RomaniaStudy on the Effects of AZD4604 on Airway Inflammation in Adults with Asthma
DenmarkStudy on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
